Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Open accessThe DOI matches its Crossref record; 244 of the 246 references it cites were found in a registry or an index.
Abstract
Background.: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. Methods.: A task force supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America searched, selected, and synthesized relevant evidence. The evidence was then used as the basis for recommendations about the diagnosis of tuberculosis disease and LTBI in adults and children. The recommendations were formulated, written, and graded using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) approach. Results.: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided. Six of the recommendations are strong, whereas the remaining 17 are conditional. Conclusions.: These guidelines are not intended to impose a standard of care. They provide the basis for rational decisions in the diagnosis of tuberculosis in the context of the existing evidence. No guidelines can take into account all of the often compelling unique individual clinical circumstances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, culture may lead to misclassification of some cases of extrapulmonary tuberculosis as ‘not tuberculosis', owing to the paucibacillary nature of the disease.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“This means that culture may have low sensitivity for extrapulmonary tuberculosis overall and further that culture sensitivity may differ for different forms of extrapulmonary tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“A recent evidence synthesis reported sensitivities of 72% to 88% in lymph node tissue, 28% to 81% in pleural fluid, 90% in pleural tissue, and 31% to 56% in CSF. Specificity ranged from 90% to 100% (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“For the 'Summary of findings' tables for CSF and pleural fluid, we provide evidence using culture as the reference standard, which is considered the best reference standard for tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 3×
“These assays are promising, but are not yet commercially available [146, 159, 160].”
BackgroundMethodGrading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732 · cited 1×
“The emergence of drug-resistant tuberculosis has become apparent over the past 2 decades, and in particular, multidrug-resistant tuberculosis (MDR-TB; resistant to isoniazid and rifampin) and extensively drug-resistant tuberculosis (XDR-TB; resistant to isoniazid and rifampin, plus any fluoroquinolone and at least 1 o…”
BackgroundSelwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574 · cited 1×
“For example, individuals who have a prior latent infection with Mtb (not treated) and then acquire HIV infection will develop TB disease at an approximate rate of 5%–10% per year (in the absence of effective HIV treatment) [18, 19].”
Background(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Self-citationMolecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Research works printed but not linked: 8
- World Health Organization, 2015, Global tuberculosis report 2015
- T-SPOT.TB: an aid in the diagosis of tuberculosis infection; package insert for in vitro diagnositic use
- Perez, 2005, Impact of screening for latent TB before initiating anti-TNF therapy in North America and Europe, Ann Rheum Dis, 64, 265
- US Food and Drug Administration, 2008, Medical devices: T-SPOT-TB—P070006
- Forbes, 2008, Laboratory detection and identification of mycobacteria; approved guideline
- Francis J. Curry National Tuberculosis Center and California Department of Public Health, 2008, Drug-resistant tuberculosis: a survival guide for clinicians
- World Health Organization, 2008, Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB)
- Ena, 1990, The usefulness and limitations of adenosine deaminase in the diagnosis of tubercular pleurisy. A meta-analytical study [in Spanish], Med Clin (Barc), 95, 333
Cited by
Items 501–600 of 992
John, M., Chhikara, A., John, D. M., Khawar, N., Brown, B., & Narula, P. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.909148 · Cited by 5
“and contact investigations should occur immediately and in person (within 24 hours) after an index case of TB is identified [4].”
BackgroundMethodInfluentialDeveloping Clinical Guidelines: 99% Faster Is Not Enough
Krishnan, J. A. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1542ed · Cited by 5
“3 compare the results of guideline panels that used versus did not use systematic reviews for 67 PICO questions across eight ATS-sponsored guidelines.(4-11).”
ResultSullivan, K. E., Bassiri, H., Bousfiha, A. A., Costa‐Carvalho, B. T., Freeman, A. F., Hagin, D., Lau, Y., Lionakis, M. S., Moreira, I., Pinto, J. A., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0436-0 · Cited by 5
“PCR for MTB can be performed [272] .”
Erol, S., Çiftçi, F., Çiledağ, A., Kaya, A., & Kumbasar, Ö. Ö. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.12.001 · Cited by 4
Kumar, V. S., Dalton, T. L., Armstrong, L., Whitesell, A. N., Li, R., & Starks, A. M. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab528 · Cited by 6
Coronin-1 levels in patients with tuberculosis
Sinha, S., Gupta, G., Biswas, S., Gupta, K., Singh, P., Jain, R., Sharma, S., & Das, B. (2021) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_4343_20 · Cited by 7
Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
Kadkhoda, K., Dee, M., & Simeone, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04754-22 · Cited by 4
Doležalová, K., Kika, V., Göpfertová, D., & Wallenfels, J. (2022) · Central European Journal of Public Health · doi:10.21101/cejph.a7499 · Cited by 6
“This is congruent with other published works that also mentioned a lower sensitivity of non-invasive diagnostic tests in non-pulmonary specimens (11, 15).”
InfluentialTabatneck, M., He, W. A., Lamb, G. S., Sun, M., Goldmann, D. A., Sabharwal, V., Sandora, T. J., Haberer, J. E., & Campbell, J. I. (2022) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003794 · Cited by 5
“4) 280 (99) 3 (1) Foreign born status Born outside the United States 64 (20) 2 (3) 59 (92) 3 (5) Born in the United States 191 (60) 1 (1) 180 (94) 10 (5) Unknown/not documented 66 (21) 0 (0) 66 (100) 0 (0) Location of testing Primary care clinic 143 (45) 1 (1) 141 (99) 1 (1) Subspecialty clinic 60 (19) 0 (0) 57 (95) 3…”
Epidemiology of Culture-Negative Pulmonary Tuberculosis—Alameda County, 2010-2019
Chen, J., Marusinec, R., Brown, R., Shiau, R., Jaganath, D., & Chitnis, A. S. (2023) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000001715 · Cited by 4
“The improved NAAT use over time may be due to public health education on TB symptoms and promoted use of NAATs directly on clinical samples.(16) At the same time, the national proportion of clinically diagnosed TB reduced by only 19% (from 16.”
Zein, S. E., Mendoza, M. A., & Wilson, J. W. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14127 · Cited by 4
“90,91 The increasing prevalence of NTM infections in immunocompromised patients high-lightstheclinicalvalueofrapidNTMidentification,potentiallyallowing quicker initiation of empiric antibiotic therapy, which may improve outcomes and slow disease progression.”
BackgroundClinical characteristics of systemic sclerosis patients with occupational silicosis
Huo, X., Zeng, Z., Lin, Y., Lin, J., & Xu, D. (2023) · Clinical Rheumatology · doi:10.1007/s10067-023-06706-5 · Cited by 4
“Pulmonary tuberculosis (TB) was diagnosed according to the guidelines of Official American Thoracic Society/Infectious Diseases Society of America/Centers for Tuberculosis [14], by the Multidisciplinary diagnosis of pulmonologists, physicians in infectious department, and radiologist.”
Freund, O., Hadad, Y., Lagziel, T., Regev, I. F., Kleinhendler, E., Unterman, A., Bar‐Shai, A., & Perluk, T. M. (2023) · Advances in respiratory medicine · doi:10.3390/arm92010003 · Cited by 4
Cipolat, M. M., Rodrigues, D. R. R., da Silveira, L. G., da Silveira, I. G., Nothaft, M. S. V., Brenol, C. V., da Silva, L. R., Pasqualotto, A. C., & Falci, D. R. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361231222134 · Cited by 8
Pulmonary Tuberculosis Mimicking a Lung Cancer: a Case Series
Nigussi, M., Woldemichael, G. H., Alemayhu, M., Yafet, M., Tarekegn, S., Hailemariam, T. M., Gissila, A., Taye, M., & Huluka, D. K. (2024) · Ethiopian Medical Journal · doi:10.4314/emj.v62i1.11 · Cited by 4
“The most common presenting symptoms in TB diagnosed patients are cough greater than 2 weeks, fever, night sweat, fatigue, anorexia and weight loss [4].”
BackgroundGoswami, N. D., & Reed, C. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae198 · Cited by 4
Olbrich, L., Kay, A. W., Bjerrum, S., Yang, B., Åhsberg, J., Nathavitharana, R. R., Lundh, A., Shah, M., & Jaganath, D. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016071 · Cited by 4
Malta, G., Serra, N., Spatola, G. F., Maida, C. M., Graziano, G., Raimondo, D. D., Fasciana, T., Caputo, V., Giammanco, A., Capuano, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123546 · Cited by 4
“Pipit ò et al. reported that in Sicily, 3745 people were hospitalized for TB, with 5239 admissions and 166 Pipitò et al. reported that in Sicily, 3745 people were hospitalized for TB, with 5239 admissions and 166 deaths from 2009 to 2021 [36]. deaths from 2009 to 2021 [36].”
BackgroundLiu, Y., Su, J., Jiang, J., Yang, B., Cao, Z., Zhai, F., Sun, W., Zhang, L., & Cheng, X. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s480173 · Cited by 4
“Notably, specificity was maintained at a high level of 0.871 (95% CI: 0.806–0.937) across both groups, demonstrating the nomogram’s consistency in ruling out TB.”
InfluentialQin, W., You, T., Guo, T., Tian, R., Cui, X., & Wang, P. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s491507 · Cited by 4
Meserve, K., Chapman, C. A., Xu, M., Zhou, H., Robison, H. M., Hilgart, H. R., Arias, P., Pathakumari, B., Reddy, M. R., Daniel, K. A., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316648 · Cited by 6
“Risk factors for TB infection, TB progression, and/ or TB reactivation were obtained through a questionnaire and review of medical records as previously described [48,49].”
Romero, A. F., Orjuela-Cañón, Á. D., Jutinico, A. L., Awad, C., Vergara, E., & Palencia, M. A. (2025) · Applied Sciences · doi:10.3390/app15105423 · Cited by 11
Management of Coinfections in Patients with Human Immunodeficiency Virus
Custer, S. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.10.001 · Cited by 4
Stockbridge, E. L., Miller, T. L., Carlson, E., & Ho, C. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193432 · Cited by 4
McCormick-Baw, C., Hollaway, R., & Cavuoti, D. (2018) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2018.08.005 · Cited by 4
Guadagnino, G., Serra, N., Colomba, C., Giammanco, A., Mililli, D., Scarlata, F., Ciaccio, M., & Carlo, P. D. (2017) · Cited by 4
Borderline-Positive Quantiferon in Children
Nygaard, U., Poulsen, A., Nielsen, A. C. Y., Ravn, P., & Vissing, N. H. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002416 · Cited by 4
Diagnostics: The Role of the Laboratory
Afzal, A., Kaplan, H. M., Motazedi, T., Qureshi, T. M., & Woc-Colburn, L. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-33803-9_4 · Cited by 4
Incidencia de tuberculosis en pacientes que reciben fármacos anti-TNFα
Gruss, A., Contrera, M., Piñeiro, N., Perna, A., Gambogi, R., Alemán, A., Correa, F., & Albornoz, H. (2020) · Revista Médica del Uruguay · doi:10.29193/rmu.36.1.2 · Cited by 4
“Sin embargo, existen condiciones que aumentan el riesgo de desarrollarla, principalmente las vinculadas a inmunodepresión por enfermedades (VIH, enfermedades autoinmunes, hematooncológicas, etcétera), o por administración de drogas inmunosupresoras((2-4)).”
BackgroundEvaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
Li, H., He, Z., Liang, J., Li, G., Xie, T., Liu, Y., Li, Z., Feng, X., Xia, Y., & Guo, X. (2020) · BioMed Research International · doi:10.1155/2020/1968487 · Cited by 4
“However, this technique has the disadvantage of being time-consuming since it can take up to several weeks to confirm the results [34, 35].”
Latent Tuberculosis Screening Using Electronic Health Record Data
Jenks, J. D., Garfein, R. S., Zhu, W., & Hogarth, M. A. (2020) · Emerging infectious diseases · doi:10.3201/eid2609.191391 · Cited by 4
Profile of Patients With Tuberculous Pleural Effusion in Qatar: A Retrospective Study
Zahid, M., Naushad, V. A., Purayil, N. K., Jamshaid, M. B., Parambil, J. V., Rashid, F. R., Ismail, S., Saddique, M. N., & Chalihadan, S. (2020) · Cureus · doi:10.7759/cureus.12391 · Cited by 4
Delgado-Argote, H., Leiva, L. M., & Rojas, C. (2021) · Biomédica · doi:10.7705/biomedica.5857 · Cited by 4
“La población infantil es más vulnerable frente a la tuberculosis diseminada y extrapulmonar; y son factores de riesgo ser menor de 5 años, presentar inmunodeficiencias, no estar vacunados con la BCG y la desnutrición (4,5), la cual constituye el principal factor de riesgo en los países endémicos en desarrollo (6).”
Gu, K.-M., Kang, H.-R., Park, J., Kwak, N., & Yim, J. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e202 · Cited by 4
Lim, R., Talavlikar, R., Chiazor, O., Bietz, J., Gardiner, H. M., & Fisher, D. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06637-z · Cited by 4
“More recently, a combined societal guideline in the United States has recommended an IGRA over a TST in those with suspected infection at low to moderate risk of disease progression, although the TST remains an acceptable alternative [10].”
BackgroundWinglee, K., Hill, A. N., Belknap, R., Stout, J. E., & Ayers, T. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.02.020 · Cited by 4
What is the significance of an accelerated BCG reaction in children?
Villanueva, P., Pittet, L. F., Nourse, C. B., & Curtis, N. C. (2022) · Archives of Disease in Childhood · doi:10.1136/archdischild-2022-323853 · Cited by 4
The Brief Case: A Real Pain in the Testicle—a Case of Extrapulmonary Mycobacterium tuberculosis
Plourde, A. R., Hall, C. R., & McElvania, E. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.00602-21 · Cited by 4
Lopez-Olivo, M. A., & Ruíz-Camps, I. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.875910 · Cited by 7
Sabella‐Jiménez, V., Méndez, Y. C. H., Benjumea‐Bedoya, D., Estupiñán-Bohorquez, A. F., Acosta-Reyes, J. L., & Flórez, I. D. (2022) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2022-001551 · Cited by 4
Bacteremia tuberculosis among HIV‐negative children in China
Chu, P., Shi, J., Dong, F., Yang, H., Zhao, S., Liu, G., Zheng, H., Liu, J., Li, H., & Lu, J. L. (2022) · Pediatric Investigation · doi:10.1002/ped4.12342 · Cited by 3
Ilyas, U., Mahmood, A., Pansuriya, A. M., Umar, Z., & Landry, I. (2022) · Cureus · doi:10.7759/cureus.29339 · Cited by 4
“In addition, performing a diagnostic nucleic acid amplification test on the initial respiratory specimen is recommended [15].”
BackgroundMethodInfluentialMacfarlane, L., Brij, S. O., Child, F., Turnbull, L., Lee, A. R., Barrera, M., & Hogan, C. (2023) · Clinical Medicine · doi:10.7861/clinmed.2022-0327 · Cited by 4
Chrissian, A. A., Silva, S. D., Quan, M., Wiltchik, E., Patel, P., Furukawa, B. S., Rogstad, D., Rockwood, N., Ho, E., & Cheek, G. A. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-83 · Cited by 3
“Furthermore, while molecular testing may be useful for guiding initial therapeutic decisions, culture-based analysis remains the gold standard for evaluating antimicrobial sensitivity (65,66).”
Pelt, C. E., Shakir, S. M., Cahill, M. J., Pupaibool, J., & Cahill, B. C. (2024) · Arthroplasty Today · doi:10.1016/j.artd.2024.101350 · Cited by 4
Bertumen, J. B., Pascopella, L., Han, E. E., Glenn-Finer, R., Wong, R. J., Chitnis, A. S., Jaganath, D., Jewell, M. P., Gounder, P. P., McElroy, S., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae169 · Cited by 4
Zhang, H. C., Zeng, J., Zhu, T., Lin, T., & Song, T. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107375 · Cited by 4
Late boosting phenomenon in TST conversion among health care workers
Farah, W. H., Breeher, L. E., Newcomb, R. D., Murad, M. H., Vaughn, A., Hagen, P. T., & Molella, R. G. (2017) · Occupational Medicine · doi:10.1093/occmed/kqx102 · Cited by 4
“Many health care institutions require serial, routine surveillance testing for HCWs, and despite evolution of guidelines recommending transition to interferon gamma release assays (IGRAs), many of these institutions continue to rely on tuberculin skin test (TST) [7].”
BackgroundCollins, J. M., Hunter, M., Gordon, W., Kempker, R. R., Blumberg, H. M., & Ray, S. M. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.59 · Cited by 4
“Potential conflicts of interest: The authors do not have a commercial or other association that might pose a conflict of interest. uthor M anuscript A uthor M anuscript A uthor M anuscript Grady Memorial Hospital are screened for TB infection at the time of hire (2-step testing is required at baseline) and annually wi…”
BackgroundMethodInfluentialArnaiz, E. V., Soriano‐Arandes, A., Espiau, M., Altet, N., Fortuny, C., Monsonís, M., Tebruegge, M., & Noguera‐Julián, A. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002517 · Cited by 4
“Given the limited evidence and the high risk of progression to active and more severe forms of tuberculosis (TB), most guidelines recommend the preferential use of tuberculin skin tests (TST) over IGRAs in children <5 years of age after close contact with a smear-positive patient with pulmonary TB, irrespective of Bac…”
BackgroundResultInfluentialTuberculosis urogenital en un paciente con falla renal, estado del arte
Nieto‐Ríos, J. F., Lopera, J. Z., Sánchez-López, S., Barrientos-Henao, S., Bello-Márquez, D. C., Hoyos, A. V., & Serna-Higuita, L. M. (2020) · IATREIA · doi:10.17533/udea.iatreia.67 · Cited by 4
Combating human bacterial infections
Mir, M. A., Nabi, B., Ahlawat, S., Kumawat, M., & Aisha, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00008-5 · Cited by 4
Liu, X., Xia, L., Zhang, A., Zhang, Y., Liu, Y., Lu, S., Song, Y., & Li, S. (2019) · Scientific Reports · doi:10.1038/s41598-018-35942-y · Cited by 4
Carnazzo, S. M., Cerruto, C., & Comisi, F. F. (2024) · Radiology Case Reports · doi:10.1016/j.radcr.2024.10.129 · Cited by 3
Bella, C. D., Motisi, M. A., Venturini, E., D’Elios, S., Asvestopoulou, E., Tamborino, A. M., Galli, L., D’Elios, M. M., & Chiappini, E. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-05972-6 · Cited by 3
Hailu, B. K., Demessie, Y., Gessese, A. T., Dagnaw, G. G., & Dejene, H. (2025) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-025-00360-7 · Cited by 3
Fischer, H. J., Qian, L., Li, Z., Bruxvoort, K. J., Skarbinski, J., Ni, Y., Ku, J. H., Lewin, B. J., Garba, S., Mahale, P. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58775-6 · Cited by 3
Kenu, S., Teklu, T., Solomon, F. B., & Alemu, G. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-00870-x · Cited by 4
Crocker-Buqué, T., Moso, M. A., Denholm, J. T., & Singh, K. P. (2025) · Current HIV/AIDS Reports · doi:10.1007/s11904-025-00746-z · Cited by 3
Identification of Specific LncRNA Markers in Severe Tuberculosis for Early Diagnosis
Yao, S., Ji, X., Wang, R., Pan, L., & Liu, Q. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s540446 · Cited by 4
“32,33 MDR-TB and XDR-TB often lead to severe consequences such as acute respiratory distress syndrome (ARDS) and other complications due to difficulties in diagnosis and treatment.”
Characteristics of tuberculosis in elderly adults: A multicenter French study
Trichet, M., Lanoix, J., Diamantis, S., Forestier, E., Fraisse, T., Brochard-Libois, J., Carine, D., Ketz, F., Henn, A., Putot, A., et al. (2025) · Infectious Diseases Now · doi:10.1016/j.idnow.2025.105226 · Cited by 3
Zhao, J., Cai, W., Zhang, X., Fang, H., Zhuge, J., Zhang, L., Wang, J., Sun, L., Hua, Z., & Fu, J. X. (2026) · BMC Microbiology · doi:10.1186/s12866-025-04707-9 · Cited by 5
“The diagnosis of PMDs was established according to the corresponding international guidelines: NTM-PD was diagnosed following the 2020 ATS/ERS/ESCMID/ IDSA Clinical Practice Guideline [7], and TB was diagnosed in accordance with the 2017 ATS/CDC/IDSA Clinical Practice Guideline [30].”
InfluentialTuberculosis Screening in Silica-Exposed Workers
Reul, N. K., Gray, Z., Braid, B. B., & Leland, M. A. (2021) · Public Health Reports · doi:10.1177/00333549211041584 · Cited by 3
“…low risk refers to patients who have no identified risk factors for either 1. having acquired TB infection (e.g. foreign-born person from a country with an elevated TB rate), or 2. having excess risk of disease progression (e.g., current or planned immunosuppressionJ_iv.v '" Lewinsohn et al. 2017.”
Zavala, S., Winglee, K., Ho, C. S., Pettit, A. C., Ahmed, A. I., Katz, D. J., Belknap, R., & Stout, J. E. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202212-1005oc · Cited by 3
Guleria, R., Chawla, R., Modi, M., Rodrigues, C. S., Jaiswal, A., Saxena, P., Biswal, M., Chaudhry, D., Peter, J. V., Sehgal, I. S., et al. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24783 · Cited by 5
Hong, Y. J., Kim, H. W., Kim, Y. S., Kim, K. H., Shin, A. Y., Choi, J. Y., Ahn, J. H., Kim, J. S., & Ha, J. H. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-143 · Cited by 3
“Culture is the gold standard microbiological test for diagnosis of TB (28).”
BackgroundTuberculous Otomastoiditis: A Diagnostic Dilemma
Yee, P. M., & Othman, I. A. (2024) · Cureus · doi:10.7759/cureus.71307 · Cited by 3
“The Joint Committee of the American Thoracic Society/Infectious Disease Society of America/Centre of Disease Control and Prevention suggested a combination of tests (microbiological, histological, and molecular), as they lack sensitivity on their own [18].”
Lü, P., Martínez, L., Xue, H., Liu, Q., Ding, X., Pan, J., Ding, H., Lü, W., Zhu, L., & Wang, J. (2025) · BMC Public Health · doi:10.1186/s12889-025-21954-7 · Cited by 3
Rotundo, S., Serapide, F., d’Ettorre, G., Tassone, M. T., Albanese, M., Marino, G. G., Tassone, B., Ceccarelli, G., & Russo, A. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05301-7 · Cited by 3
Common Infections Following Lung Transplantation
Marriott, D. J. E., & Morrissey, C. O. (2018) · Springer eBooks · doi:10.1007/978-3-319-90933-2_15 · Cited by 3
Alcaide, F., Trastoy, R., Moure, R., González-Bardanca, M., Ambroa, A., López, M. C., Bleriot, I., Blasco, L., Fernández-García, L., Tato, M., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00733-19 · Cited by 3
“Unfortunately, the conventional microbiological diagnosis of TB has important limitations, such as the poor sensitivity of acid-fast bacillus detection by microscopy and the slow growth of the tubercle bacillus in culture media (4).”
Low Prevalence of Latent Tuberculosis Infection among Contacts of Smear-Positive Adults in Brazil
Oliveira-Cortez, A., Froede, E. L., de Melo, A. C., Sant’Anna, C. C., Pinto, L. A., da Rocha, E. M. M., Oliveira, C. D. L., & Camargos, P. A. M. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0100 · Cited by 3
Urine Microscopy: The Burning Truth – White Blood Cells in the Urine
Vitale, A., & Lockwood, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-29138-9_8 · Cited by 3
Mehtani, N. J., Puryear, S. B., Pham, P. A., Dooley, K. E., & Shah, M. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab319 · Cited by 3
Diabetes Melitus Sebagai Faktor Risiko Tuberkulosis
Nugraha, I. B. A., Gotera, W., & Yustin, W. E. F. (2021) · Jurnal Kedokteran Meditek · doi:10.36452/jkdoktmeditek.v27i3.2126 · Cited by 3
Differential Diagnosis of Inflammatory Arthropathy Accompanying Active Tuberculosis Infection
Jung, Y., & Choi, B. Y. (2022) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2022.29.2.108 · Cited by 4
“To confirm TB arthritis, synovial fluid aspiration or synovial biopsy is necessary for microbiological tests, such as AFB smear/culture and TB PCR or histopathologic examination [16].”
BackgroundTuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
İlgen, U., Karadağ, Ö., Emmungil, H., Küçükşahin, O., Koca, S. S., Erden, A., Beş, C., Kanıtez, N. A., Dalkılıç, E., Akar, S., et al. (2022) · Rheumatology International · doi:10.1007/s00296-022-05134-z · Cited by 3
“They are not affected by latent infections by most NTMs and BCG vaccination [1, 9, 12].”
Sarcoidosis of the breasts – when should it be considered? A case report
Jaguś, D., Yafimtsau, I., Mlosek, K., Jończak, L., Roszkowska‐Purska, K., & Dobruch‐Sobczak, K. (2022) · Journal of Ultrasonography · doi:10.15557/jou.2022.0022 · Cited by 3
“Subsequent diagnostic work-up of pulmonary lesions detected no presence of acid-fast bacilli in the bacteriological examination of bronchoalveolar lavage (BAL)(8,9).”
BackgroundResponding to the post-pandemic crisis: post-exposure prophylaxis for TB
Heffernan, C., Savić, R. M., Long, R., Raviglione, M. C., & Ferrara, G. (2022) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.22.0342 · Cited by 3
Bahuaud, O., Genestet, C., Hoffmann, J., Dumitrescu, O., & Ader, F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.998972 · Cited by 3
Bahmad, H. F., Azimi, R., Kilinc, E., Tuda, C. D., & Vincentelli, C. (2022) · Diseases · doi:10.3390/diseases10040096 · Cited by 3
“When pulmonary tuberculosis infection is suspected clinically and on imaging studies, the 2017 ATS/IDSA/CDC tuberculosis diagnosis guidelines recommend that postbronchoscopy sputum specimens be obtained [14].”
A Longitudinal Study of Multimodal Bronchoscopy Training in Uganda
Karmali, D., Argento, A. C., Kirenga, B., Batra, H., Lee, H. J., MacRosty, C. R., Lerner, G. R., Siddharthan, T., Worodria, W. O., & Jackson, P. (2023) · ATS Scholar · doi:10.34197/ats-scholar.2022-0080oc · Cited by 3
“These studies align with current guidelines, which suggest performing flexible bronchoscopy and obtaining bronchial alveolar lavage (BAL) or bronchial washing samples to diagnose pulmonary infections in immunocompromised individuals when noninvasive samples cannot be obtained or if an alternative diagnosis is being co…”
BackgroundResultLatent tuberculosis infection in liver transplant patients: a review
Cardenas, J., Campos-Bonaguro, M. E., & Simkins, J. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000003 · Cited by 3
“[5,6] Immunodiagnostic challenges[7] are summarized in Table 1.”
BackgroundMurrugarra, L. K. S., de Lima, L. V., Pavinati, G., Palmieri, I. G. S., Monteiro, L. R. D. S., Gil, N. L. D. M., & Magnabosco, G. T. (2023) · Revista de Saúde Pública do Paraná · doi:10.32811/25954482-2023v6n1.709 · Cited by 3
Arumairaj, A. J., Park, H., Quesada, F., Altonen, B. L., Chaudhari, S., Mattana, J., & Habtes, I. (2023) · Cureus · doi:10.7759/cureus.39272 · Cited by 4
“This study confirms that if the TST induration is 10mm and more, irrespective of the status of the BCG vaccination, the TST induration is likely because of LTBI and is less likely because of cross-reaction with BCG vaccination [30].”
BackgroundSeo, W. J., Koo, H., Kang, J. Y., Kang, J., Park, S. H., Kang, H. K., Park, H. K., Lee, S.-S., Choi, S., Jang, T. W., et al. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02646-7 · Cited by 3
“If molecular tests, including the nucleic acid amplification test or tissue biopsy reveal characteristic findings, such as granulomatous inflammation accompanied by caseous necrosis, TB could be diagnosed [21, 22].”
BackgroundVolkman, T., Muruganandah, V., Graham, H., Tosif, S., Stokes, S., & Ranganathan, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295913 · Cited by 3
Cheng, X., Chen, L., Wan, W., Peng, J., Wu, L., Xin, J., & Cai, J. (2024) · Medicine · doi:10.1097/md.0000000000037039 · Cited by 6
“[5] In the present study, the combination of GeneXpert MTB/RIF and Gene chip for Mycobacterium strain identification yielded the highest AUC, but it was still lower than that in previous studies conducted in various populations of patients with TB. [20–25] On the other hand, the GeneXpert MTB/RIF…”
BackgroundMethodResultInfluentialCharacteristics of TB cases without documented sputum culture in the United States, 2011–2021
Rautman, L., Kammerer, J. S., Silk, B. J., Marconi, V. C., Youngblood, M., Edwards, J. A., Wortham, J. M., & Self, J. (2024) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.23.0432 · Cited by 3
Bjerrum, S., Yang, B., Åhsberg, J., Nathavitharana, R. R., Olbrich, L., Jaganath, D., Kay, A. W., Lundh, A., & Shah, M. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016070 · Cited by 3
Travel-Associated Infections and Diseases
Halsey, E. S. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780197788547.003.0004 · Cited by 3
Too little too late: Waiting for TB to come
Kawamura, L. M. (2018) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2018.01.002 · Cited by 4
“Unlike the skin test, IGRAs are not impacted by prior Bacillus Calmette–Guérin (BCG) vaccination or most non-tuberculous mycobacterial bacilli, and they require only one patient visit instead of two to get a result.(6) In large prospective LTBI prevalence trials in China and Vietnam comparing an IGRA to tuberculin ski…”
BackgroundRapidly Growing Mycobacterium tuberculosis in the Form of Empyema Necessitans: A Case Report
Chang, S. H., Choe, J., Ghandehari, S., Chaux, G. E., Chung, A. P., Ramzy, D., Megna, D. J., Falk, J., & Zakowski, P. C. (2021) · Journal of Intensive Care Medicine · doi:10.1177/08850666211044100 · Cited by 3
“MTB generally grows slowly on culture, taking 2 or more weeks to be detected and requiring up to 6 to 8 weeks before cultures can be definitively declared negative for MTB growth.(2,4,5) However, accelerated growth of AFB culture, as seen in our case as less than 6 days, does not rule out MTB.”
BackgroundPaediatric progressive primary tuberculosis
Yogo, N., Furukawa, C., & Hayano, S. (2022) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2022.100318 · Cited by 3
Chronic nasopharyngeal and otitis media tuberculosis: diagnosis and management difficulties
Pais, J. P., Caçador, M., Mourato, T., & Paço, J. C. (2022) · BMJ Case Reports · doi:10.1136/bcr-2022-250690 · Cited by 3
The uncertain science of predicting tuberculosis
Togun, T. O., & Pai, M. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30059-0 · Cited by 3
Self-citationKohlmorgen, B., Elias, J., & Schoen, C. U. (2017) · Scientific Reports · doi:10.1038/s41598-017-14367-z · Cited by 3
Tuberculosis Infection in Children
Stewart, R. J., Wortham, J. M., Parvez, F. M., Morris, S. B., Kirking, H. L., Cameron, L. H., & Cruz, A. T. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.06.027 · Cited by 3
Mehershahi, S., Haider, A., Fortuzi, K., Shaikh, D. H., & Patel, H. K. (2021) · Case Reports in Gastroenterology · doi:10.1159/000514892 · Cited by 3
Dubisi, F. A., Harvey, G., Ostrow, O., Lam, R. E., Science, M. E., & Kitai, I. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab435 · Cited by 3
“Obtaining sputum either in the ED or soon after the visit would have expedited diagnosis [11].”
Metadata
- Authors
- Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., O’Brien, R. J., Pai, M., Richeldi, L., Salfinger, M., Shinnick, T. M., Sterling, T. R., Warshauer, D. M., & Woods, G. L.
- Affiliations
- Oregon Health & Science University (US)
- Emory University School of Medicine and
- Centers for Disease Control and Prevention (US)
- Denver Public Health (US)
- National Jewish Health (US)
- California Department of Public Health (US)
- St. James's Hospital (IE)
- Francis J. Curry International TB Center, San Francisco, California;
- FIND (CH)
- McGill University (CA)
- University of Southampton (GB)
- Vanderbilt University (US)
- Wisconsin State Laboratory of Hygiene, Madison, and
- University of Arkansas for Medical Sciences (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-08
- Volume
- 64
- Issue
- 2
- Pages
- e1-e33
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5504475
- OpenAlex
- W2559832962
- Cited by
- 992
- References
- 246
- Citations by year
- 2026: 65 · 2025: 81 · 2024: 91 · 2023: 101 · 2022: 115 · 2021: 142 · 2020: 133 · 2019: 110 · 2018: 96 · 2017: 55 · 2016: 1
- FWCI
- 80.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, latent tuberculosis infection, pulmonary tuberculosis, extrapulmonary tuberculosis, Mycobacterium tuberculosis, diagnostic testing, children, adults
- MeSH terms
- Adult, Age Factors, Child, Humans, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Pulmonary, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.